1.Wang H, Mu J, Chen Y, Liu Y, Li X, Li H, Cao P. Hybrid Ginseng-derived Extracellular Vesicles-Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis. Adv Sci (Weinh). 2024 Feb 14:e2308235. 

2.Rosell R, Cao P. Promising outlook with sugemalimab in non-small-cell lung cancer. Lancet Oncology. 2022; 2045(21)00698-7. 

3.Han X, Wei Q, Lv Y, Weng L, Huang H, Wei Q, Li M, Mao Y, Hua D, Cai X, Cao M, Cao P. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Mol Ther. 2022;30(1):327-340. 

4.Yang J, Ling Y, Hua D, Zhao C, Sun X, Cai X, Chen J, Hu C, Cao P. IL-6R blockade by chikusetsusaponin IVa butyl ester inhibits Th17 cell differentiation and ameliorates collagen-induced arthritis. Cell Mol Immunol. 2021;18(6):1584-1586.

5.Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, Lu W, Wei Q, Ye J, Cai X, Hu C, Yin X, Cao P. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer. 2019;7(1):326.

6.Sun X, Wang W, Chen J, Cai X, Yang J, Yang Y, Yan H, Cheng X, Ye J, Lu W, Hu C, Sun H, Pu J, Cao P. The natural diterpenoid isoforretin A inhibits thioredoxin-1 and triggers potent ROS-mediated antitumor effects. Cancer Res. 2017, 77, 926-936.

1.国家重点研发计划（2023YFC2308200），抗病毒感染性疾病中药的筛选与药效物质基础研究，2024/01-2026/12，主持。

2.国家自然科学基金重点项目（82230120），搜风散结方调控MDSCs-Th17/Treg轴治疗类风湿关节炎的免疫学机制，2023/01-2027/12，主持。

3.国家杰出青年科学基金（82125037），中药抗肿瘤药理研究，2022/01-2026/12，主持。

4.江苏省社会发展-临床前沿技术项目（BE2022815），黄芪桂枝五物汤治疗紫杉醇化疗神经毒性的临床疗效评价和作用机制研究，2022/07-2025/06，主持。

5.国家优秀青年科学基金（81622048），动物药多肽物质基础与功能，2017/01-2019/12，主持。

6.国家重大新药创制科技重大专项（2019ZX09301-145），化疗神经毒性治疗中药—黄芪桂枝五物颗粒的临床前研究，2019/01-2020/12，主持。

1.Wang H, Mu J, Chen Y, Liu Y, Li X, Li H, Cao P. Hybrid Ginseng-derived Extracellular Vesicles-Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis. Adv Sci (Weinh). 2024 Feb 14:e2308235. 

2.Rosell R, Cao P. Promising outlook with sugemalimab in non-small-cell lung cancer. Lancet Oncology. 2022; 2045(21)00698-7. 

3.Han X, Wei Q, Lv Y, Weng L, Huang H, Wei Q, Li M, Mao Y, Hua D, Cai X, Cao M, Cao P. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Mol Ther. 2022;30(1):327-340. 

4.Yang J, Ling Y, Hua D, Zhao C, Sun X, Cai X, Chen J, Hu C, Cao P. IL-6R blockade by chikusetsusaponin IVa butyl ester inhibits Th17 cell differentiation and ameliorates collagen-induced arthritis. Cell Mol Immunol. 2021;18(6):1584-1586.

5.Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, Lu W, Wei Q, Ye J, Cai X, Hu C, Yin X, Cao P. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer. 2019;7(1):326.

6.Sun X, Wang W, Chen J, Cai X, Yang J, Yang Y, Yan H, Cheng X, Ye J, Lu W, Hu C, Sun H, Pu J, Cao P. The natural diterpenoid isoforretin A inhibits thioredoxin-1 and triggers potent ROS-mediated antitumor effects. Cancer Res. 2017, 77, 926-936.